177Lu-DOTATATE in neuroendocrine tumors: Real-world evidence of efficacy and safety in a community setting

被引：0
|
作者：
Sassic, Jessica
Farasat, Sadaf
Hermel, David
Sigal, Darren
Xavier, Marin Feldman
机构：
[1] Scripps Mercy Hosp, San Diego, CA USA
[2] Scripps Green Hosp, Scripps Clin, La Jolla, CA USA
[3] Scripps Clin, La Jolla, CA USA
[4] Scripps Clin, San Diego, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16249
引用
收藏
页数：1
相关论文
共 50 条
  • [21] 177Lu-Dotatate efficacy and safety in functioning neuroendocrine tumors: A joint analysis of phase 2 prospective clinical trials
    Bongiovanni, A.
    Nicolini, S.
    Ibrahim, T.
    Foca, F.
    Sansovini, M.
    Grassi, I
    Liverani, C.
    Fausti, V
    Di Menna, G.
    Maiorano, B. A.
    Paganelli, G.
    Severi, S.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 175 - 175
  • [22] 177Lu-DOTATATE efficacy and safety in functioning neuroendocrine tumors: A joint analysis of phase II prospective clinical trials
    Bongiovanni, A.
    Nicolini, S.
    Foca, F.
    Sansovini, M.
    Grassi, I.
    Liverani, C.
    Riva, N.
    Fausti, V.
    Mercatali, L.
    De Vita, A.
    Fabbri, L.
    Signoretti, M.
    Pacilio, C. A.
    Paganelli, G.
    Severi, S.
    Ibrahim, T.
    Tartaglia, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S912 - S912
  • [23] 177Lu-DOTATATE Efficacy and Safety in Functioning Neuroendocrine Tumors: A Joint Analysis of Phase II Prospective Clinical Trials
    Bongiovanni, Alberto
    Nicolini, Silvia
    Ibrahim, Toni
    Foca, Flavia
    Sansovini, Maddalena
    Di Paolo, Arianna
    Grassi, Ilaria
    Liverani, Chiara
    Calabrese, Chiara
    Ranallo, Nicoletta
    Matteucci, Federica
    Paganelli, Giovanni
    Severi, Stefano
    CANCERS, 2022, 14 (24)
  • [24] Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE
    Strosberg, Jonathan R.
    Srirajaskanthan, Rajaventhan
    El-Haddad, Ghassan
    Wolin, Edward M.
    Chasen, Beth R.
    Kulke, Matthew H.
    Bushnell, David L.
    Caplin, Martyn E.
    Baum, Richard P.
    Hendifar, Andrew E.
    Oberg, Kjell
    Ruszniewski, Philippe
    Santoro, Paola
    Broberg, Per
    Leeuwenkamp, Oscar R.
    Krenning, Eric P.
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (12) : 1712 - 1718
  • [25] Therapeutic response evaluation in patients with neuroendocrine tumors treated with 177Lu-DOTATATE
    Gupta, Santosh
    Damle, Nishikant
    Bal, Chandrasekhar
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [26] Dosimetric Quantities in Neuroendocrine Tumors over Treatment Cycles with 177Lu-DOTATATE
    Roth, Daniel
    Gustafsson, Johan
    Warfvinge, Carl Fredrik
    Sundlov, Anna
    Akesson, Anna
    Tennvall, Jan
    Gleisner, Katarina Sjogreen
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (03) : 399 - 405
  • [27] Prognostic factors in patients with advanced neuroendocrine tumors treated with 177Lu-DOTATATE
    Casanovas, M. Mitjavila
    Percovich, J.
    Bello, P.
    Arbizu, J.
    Pubul, V.
    Riesco, M.
    Muros, M.
    Gonzalez, E.
    Carmona-Bayonas, A.
    Estenoz, J.
    Rotger, A.
    Llana, B.
    Aller, J.
    Jimenez-Fonseca, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S593 - S594
  • [28] 177Lu-DOTATATE PRRT Safety and Organ-at-Risk Dosimetry in Patients With Gastroenteropancreatic Neuroendocrine Tumors
    Mileva, Magdalena
    Van Bogaert, Camille
    Marin, Gwennaelle
    Danieli, Rachele
    Artigas, Carlos
    Levillain, Hugo
    Ameye, Lieveke
    Taraji-Schiltz, Loubna
    Stathopoulos, Konstantinos
    Wimana, Zena
    Hendlisz, Alain
    Flamen, Patrick
    Karfis, Ioannis
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (09) : 847 - 853
  • [29] Blood-based Genomic Assessment of Clinical Efficacy and Toxicity of 177Lu-DOTATATE of Neuroendocrine Tumors
    Bodei, Lisa
    Raj, Nitya
    Do, Kinh Gian
    Krebs, Simone
    Reidy-Lagunes, Diane
    Kidd, Mark
    Drozdov, Ignat
    Modlin, Irvin
    Schoder, Heiko
    PANCREAS, 2022, 51 (03) : E47 - E47
  • [30] NAMPT Inhibitor GMX1778 Enhances the Efficacy of 177Lu-DOTATATE Treatment of Neuroendocrine Tumors
    Elf, Anna-Karin
    Bernhardt, Peter
    Hofving, Tobias
    Arvidsson, Yvonne
    Forssell-Aronsson, Eva
    Wangberg, Bo
    Nilsson, Ola
    Johanson, Viktor
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (02) : 288 - 292
12345